AKRO - Akero Therapeutics Class Action Investigation: Johnson Fistel has Commenced an Investigation on Behalf of Shareholders | Benzinga
SAN DIEGO, March 15, 2024 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP is investigating whether Akero Therapeutics, Inc. ("Akero" or "the Company") (NASDAQ:AKRO) or any of its executive officers or others violated securities laws by misrepresenting or failing to timely disclose material, adverse information to investors. The investigation focuses on investors' losses and whether they may be recovered under federal securities laws.
What if I purchased Akero securities? If you purchased securities and suffered losses on your investment, join our investigation now: